Medical Affairs Unscripted | The Patient Impact in Drug Development and Value Demonstration

Episode 23 of the Medical Affairs Unscripted podcast series with with Len Lichtenfeld, MD, MACP.

Now, more than ever, the patient voice is being heard by the pharmaceutical industry. 

In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Len Lichtenfeld, MD, MACP meet to discuss the ways patients are providing advisement in drug development and valuation.

After hearing about Len’s extensive experience, they delve into the new regulatory changes coming to pharma and biotech that will require the patient experience to be taken into consideration during the drug development process. They conclude by discussing how the patient experience is having an impact on the valuation of new drugs.

Podcast Series: Medical Affairs Unscripted

Hosted by Dr Peggy Crowley-Nowick, in Medical Affairs Unscripted we explore a range of topics related to the strategic role of medical affairs from the perspective of industry experts. Through these conversations with our guests we will share first hand experience to provide the listener with insights and knowledge about the evolving role of medical affairs.

Episode guest

Len Lichtenfeld, MD, MACP